Beacon Biosignals, Inc. is a Boston-based company specializing in EEG neurobiomarker technology, designed to accelerate clinical trials and develop new treatments for patients with neurological and psychiatric diseases.
Their end-to-end augmented EEG platform, including the state-of-the-art Dreem Headband and world-class clinico-EEG database, enables precise assessment of treatment efficacy, identification of optimal patient populations, and improved probability of trial and regulatory success.
Generated from the website